About 200 reports

  • WHAT IS A BIOSIMILAR?
  • What Is a Biosimilar?

Biosimilars in Oncology Report Code: GDHCHT## Published: August 2018 Healthcare TABLE OF CONTENTS (##/ ##) ##.

  • Biosimilar
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

Global Biosimilars and Follow-On Biologics Market 2019-2029 ## Report Overview ##. ## Biosimilar Overview ##. ## Biosimilars Market Segmentation ##. ## Why You Should Read this Report ##. ## How this Report Delivers ##. ## Main Questions Answered by this Report ##. ## Who i

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Shares
  • Market Size

REST OF WORLD PART D: ANNEXURE ##.

  • Biosimilar
  • Europe
  • North America
  • World
  • Market Shares

Global Biosimilars Partnering Terms and Agreements 2014 to 2019 Chapter ## – Introduction Chapter ## – Trends in Biosimilars dealmaking ##. ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Demand
  • 6. The Biosimilar Pipeline
  • OUTSOURCE BIOSIMILAR PRODUCTION?

THESE TABLES ARE SUMMARIZED IN Figure ##: Waves of Biosimilar Opportunity by Patent Expiry of Innovator Biologics.

  • Biosimilar
  • AbbVie Inc.
  • Alexion Pharmaceuticals, Inc.
  • Amgen Inc.
  • AstraZeneca PLC

ZYDUS CADILA Chapter ## Appendix: Abbreviations List of Tables Summary Table : Global Market for Biosimilars, by Type, Through 2022 Table ## : List of Biosimilars Produced in E.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Approval process for biosimilars in US
  • Biosimilars market opportunities

Factors such as the patients and physician’s willingness to switch to biosimilars and the price advantage of biosimilars over biologics, will provide considerable growth opportunities to biosimilars manufactures.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Market Size
  • Biosimilars
  • Concerns with biosimilars

Familiarity with biosimilar IFX ##% of physicians reported having prescribed Remsima to at least one IBD patient & ##% of physicians have prescribed Inflectra to one of their IBD patients Physicians were generally more familiar with Remsima & Inflectra

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Remicade group

GLOBAL BIOSIMILAR MONOCLONAL ANTIBODIES FORECAST 2018-2028 ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Shares
  • Market Size

##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size
  • Defining Biosimilars
  • Biosimilars in South Korea

UBS; ##-##.

  • Biosimilar
  • Amgen Inc.
  • Biocon Limited
  • Celltrion, Inc.
  • Pfizer Inc.

In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer periods of time as compared to biosimilars.

  • Biobetters
  • Biosimilar
  • Medical Biotechnology
  • Asia
  • Forecast

Biosimilars Market By Product, By Technology, By Indication, By Manufacturing Type, By Route of Administration, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024 Chapter ##.

  • Biosimilar
  • Europe
  • North America
  • World
  • Market Size

##.

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • World
  • Market Size
  • RECENT DEVELOPMENTS IN BIOSIMILAR IN JAPAN
  • GLOBAL BIOSIMILARS MARKET - OVERVIEW

Note: ##.

  • Biosimilar
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 ## Preface ## Scope and Methodology ##. ## Objectives of the Study ##. ## Stakeholders ##. ## Data Sources ##. ##. ## Primary Sources ##. ##. ## Secondary Sources ##. ## Market Estimation ##. ##. ## Bottom-Up App

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size
  • BIOGENERICS
  • BIOSIMILARS

TABLE OF CONTENTS (##/ ##) ##.

  • Biosimilar
  • Medical Biotechnology
  • Market Size
  • Supply
  • Remicade group

Biosimilars Real World Evidence: Proving the point ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • World

Biosimilars Market Snapshot Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025 Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025 Table ## Global Oncology Biosimilars Marke

  • Biosimilar
  • Medical Biotechnology
  • APAC
  • World
  • Market Size

Commercialisaton of Biosimilars: Multifunctional teamwork for success ##.

  • Biosimilar
  • Medical Biotechnology
  • World

Biosimilar Commercial Strategies and Tactics CONTENTS ## OVERVIEW ## In order to realize the biosimilar opportunity, companies must understand the barriers to commercial success and leverage expertise from multiple stakeholder groups ## When firms begin to define a

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Europe
  • United States

Biosimilars: EU Payer Perspectives ##.

  • Biosimilar
  • Medical Biotechnology
  • Europe
  • Sandoz Major Biosimilar Pipeline
  • Biosimilars Vs Generics

Global Biosimilar Market: Size, Trends & Forecasts (2016-2020) November 2016 ##.

  • Biosimilar
  • Amgen Inc.
  • Celltrion, Inc.
  • Pfizer Inc.
  • Sandoz Inc.

APAC Biosimilar Market, Forecast 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Market Size

US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Market Size
  • 8.3.1 BIOSIMILARS
  • 7.2.2 PIPELINE BIOSIMILARS

ONE MAJOR DRIVER OF THIS DECLINE IS THE ENTRY OF BIOSIMILARS INTO THE MARKET.

  • Biosimilar
  • Demand
  • Forecast
  • Pfizer Inc.
  • Sanofi S.A.

Physician reluctance to use biosimilars interchangeably with the original product may prove to be an issue, albeit one that can be overcome with education efforts.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Forecast

The European population is ageing with around one fifth of the total EU population above ## years of age.

  • Biosimilar
  • Medical Biotechnology
  • Europe
  • Market Size

ASEAN and China Biosimilars Market by Molecule Type, and Application: Opportunity Analysis and Industry Forecast, 2017 - 2025 CHAPTER ##: INTRODUCTION ##. ##.

  • Biosimilar
  • Medical Biotechnology
  • ASEAN
  • China
  • Market Size
  • 9.4.1 TERIPARATIDE BIOSIMILARS
  • 2.5 BIOSIMILARS WILL DOMINATE THE MARKET IN 2027

Springer-Verlag, ##(##), pp. ##-##. doi: ##. ##/ s##-##- ##-##.

  • Biosimilar
  • United States
  • World
  • Amgen Inc.
  • Eli Lilly & Co.